Oncolytic Virus Therapy Market Size, Growth, Share, Competitive Analysis and Future Trends 2027: MarkNtel Advisors

Market Insights

As per recent research by MarkNtel Advisors, The Global Oncolytic Virus Therapy Market is projected to witness 20.3% growth during the forecast period, i.e., 2022-27.

Key Drivers

Increasing technological advancements in cancer treatments & the development of new therapies
Growing adoption of advanced therapeutic options & rising cancer cases
Research & Development initiatives & investments by healthcare providers

“In case you missed it, we are currently revising our reports. Click on the below to get the latest research data with forecasts for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.”

Request Free Sample Report: https://www.marknteladvisors.com/query/request-sample/oncolytic-virus-therapy-market.html

Market Segmentation and Consumer Behavior:

By Therapy

IMLYGIC (Talimogene Laherparepvec)
Oncorine
RIGVIR Immunotherapy
Onyx-15
Reolysin

By Application

Solid Tumor
- Breast Cancer
- Prostate Cancer
- Lung Cancer
- Glioblastoma/Glioblastoma Multiforme
Melanoma
Hematological Malignancies
- Lymphoma
- Leukemia
- Myeloma

By Type of Virus

Genetically Engineered Oncolytic Virus
- Herpes Simplex Virus(HSV)
- Adenovirus
- Vaccinia Virus
Oncolytic Wild Type of Viruses
- Myxoma
- Vesicular Stomatitis Virus (VSV)
- Newcastle Disease Virus (NDV)
- Reovirus (Respiratory Enteric Orphan Virus)

By End-User

Hospitals
Clinics
Patients
Cancer Research Institutes

Read Full Report: https://www.marknteladvisors.com/research-library/oncolytic-virus-therapy-market.html

Oncolytic Virus Therapy Market Geographical Analysis:

By Region:

North America
South America
Europe
Middle East & Africa
Asia-Pacific

Key Players and Competitive Strategies in the Oncolytic Virus Therapy Market

Several prominent players dominate the Oncolytic Virus Therapy Market, including:

Amgen Inc.
Daiichi Sankyo Company Limited
DNAtrix
Genelux Corporation
Oncolytics Biotech Inc.
PsiOxus Therapeutics
RIGVIR Ltd.
Shanghai Sunway Biotech Co. Ltd.
SillaJen Inc.
Sorrento Therapeutics Inc.
Takara Bio Inc.
Lokon Pharma AB
VCN Biosciences
ViroCure Inc.
Viralytics Ltd. (Merck & Co. Inc.)

Report Delivery - MarkNtel Advisors offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Questions Addressed in this Study

1.What factors are driving the Oncolytic Virus Therapy Market growth?

2.How is the Oncolytic Virus Therapy Market expected to grow over the next five years?

3.What are the key insights into the current trends in the Oncolytic Virus Therapy Market?

4.What is the current size of the Oncolytic Virus Therapy Market, and how is it projected to change in the future?

5.What is the future outlook for the Oncolytic Virus Therapy Market in terms of technological advancements and market expansion?

Request Customization - https://www.marknteladvisors.com/query/request-customization/oncolytic-virus-therapy-market.html

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.